References
Jaiswal JV, Wadegaonkar PA, Hajare SW (2012) The bioflavonoid galangin suppresses the growth of ehrlich ascites carcinoma in Swiss Albino mice: a molecular insight. Appl Biochem Biotechnol 167:1325–1339
Kim DA, Jeon YK, Nam MJ (2012) Galangin induces apoptosis in gastric cancer cells via regulation of ubiquitin carboxy-terminal hydrolase isozyme L1 and glutathione S-transferase P. Food Chem Toxicol 50:684–688
Tolomeo M, Grimaudo S, Di Cristina A, Piptone RM, Dusonchot L, Meli M, Crosta L, Gebbia N, Invidiata FP, Titone L, Simoni D (2008) Galangin increases the cytotoxic activity of imatinib mesylate in imatinib-sensitive and imatinib-resistant Bcr-Abl expressing leukemia cells. Cancer Lett 265:289–297
Zhang HT, Luo H, Wu J, Lan LB, Fan DH, Zhu KD, Chen XY, Wen M, Liu HM (2010) Galangin induces apoptosis of hepatocellular carcinoma cells via the mitochondrial pathway. World J Gastroenterol 16:3377–3384
Zhang W, Lan Y, Huang Q, Hua Z (2012a) Galangin induces B16F10 melanoma cell apoptosis via mitochondrial pathway and sustained activation of p38 MAPK. Cytotechnology. Sep 22 [Epub ahead of print]
Zhang HT, Wu J, Wen M, Su LJ, Luo H (2012b) Galangin induces apoptosis in hepatocellular carcinoma cells through the caspase 8/t-Bid mitochondrial pathway. J Asian Nat Prod Res 14:626–633
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kapoor, S. Galangin and its emerging anti-neoplastic effects. Cytotechnology 65, 467–468 (2013). https://doi.org/10.1007/s10616-012-9507-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10616-012-9507-5